FYI: FDA habla español

Share this article:

The FDA's watchdogs are putting their language skills to use. Regulatory Focus reports that the regulator issued a Warning Letter to website owner Ramon Rosa for misbranding his products.

Rosa claimed his drugs could treat illnesses including cancer, ringworm, diabetes and arthritis, and the FDA says it has not approved these claims. What makes this Warning Letter different is that it is about materials written in Spanish.

RF notes that the majority of the FDA's promotional monitoring focuses on English language promos, but that it has the authority to review Spanish-language materials if they are published in Puerto Rico—which is where Rosa is based.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.